Latest posts tagged with #Lobular on Bluesky
" ... when ppl see a visualization of what’s going on in their arteries, something clicks & they get motivated.'" 2/2 #CanSky
Just a reminder that mammograms aren't that good at detecting #lobular #breastcancer yet, esp w/ #densebreasts. Let's fix that, too!
www.washingtonpost.com/health/2026/...
I can’t believe I’m ending the year 10 years NED. I was dx with invasive #lobular in my 30’s. My feelings are complex, so here’s a short blog post about it. #breastcancer #survivorship #blogger
Pic credit: @breastcancerorg.bsky.social
warriormegsie.com/2025/12/27/1...
Really great session on #lobular #breastcancer at #SABCS25. TY Steffi Oesterreich, Otto Metzger, Anne Vincent Salomon, Flora Migyanka, etc. 4 sharing key insights N2 our oddball #breastcancer subtype. Gr8 2 know there are more #clinicaltrials coming! @elbcc-2018.bsky.social @lobularbca.bsky.social
This Giving Tuesday, stand with LBCA in support of the lobular breast cancer community. Donate today to fuel ILC research, awareness, education, and advocacy: lobularbreastcanceralliance-bloom.kindful.com #GivingTuesday #LBCA #lobular #ILC #invasivelobularcarcinoma #breastcancer
Always happy 2C more focused research on #lobular #breastcancer! TY @mjsikora.bsky.social 🙏
Conclusion: #ILC presents unique clinical challenges among #breastcancers, from its subtle manifestation making early detection difficult, 2 resistance 2 convent'al txs like chemo & ..." 1/2 #CanSky #Bcsm
Additional information can be found at lobularbreastcancer.org @lobularbca.bsky.social
I did not find a lump as was stated in the story. Please report any changes to your doctor. Lobular has a different presentation that other breast cancers. A lump is not typically formed. #lobular
#LOBSTER trial #GBG118 for pts with #lobular #breastcancer: It investigates whether the combination of #capivasertib + #fulvestrant can achieve a stronger therapeutic effect than fulvestrant alone – aiming to reduce #recurrence risk and improve quality of life.
👉 www.gbg.de/en/trials/lo...
Great 2C #lobular #breastcancer coverd by @cbsnews.com but it wld have been helpful 2 mention:
*Lobular #BC dsn't usually make lumps
*So it's often not felt or seen on mamms
*Esp in dense breast tissue
*It's abt changes, not lumps!
*More info @lobularbca.bsky.social
#CanSky #MedSky #CancerBS #bcsm
Coming right up Wed Oct 15! 👀
Join me & other #lobmob members 4 #ILC insights from @fredhutch.org #lobular #breastcancer experts Chris Li, Hannah Linden & Diana Lam. #CanSky @elbcc-2018.bsky.social 👇
Spotlight on lobular #BC: What pts, PCPs & oncologists need to know
share.google/Lx4Fcu6Ar7mu...
Very pleased to see this report from @americancancersoc.bsky.social on #lobular #breastcancer acsjournals.onlinelibrary.wiley.com/doi/10.1002/...
Learn more abt #lumpless #lobular at this FREE special spotlight presentation @fredhutch.org Oct 15, 3-5pm. Read more and register here. 👇
"Conclusion: ILC (invasive #lobular #breastcancer) has distinctive characteristics that can contribute 2 delayed detection, resistance 2 therapy & poorer prognosis 4 adv disease. Differentiating ILC from ductal #BC in research & clinical trials could help identify risk factors ..." 1/2 #CanSky #bcsm
Curious abt #lumpless #lobular #breastcancer? I'm hosting this event on Wed, Oct 15, 3-5 pm at #FredHutch @fredhutch.org in #Seattle w/Drs. Chris Li, Hannah Linden & Diana Lam. Learn abt #lobularBC history #imaging issues, new research & #CTs! #lobmob #CanSky @thankscancer.bsky.social #bcsm #lbca
I had the amazing opportunity to chat w @projbridgeco.bsky.social to talk about the lab, my career, studying #lobular breast cancer, and working w patient advocates. Loved talking re where I've been & talk about what's important to me as a PI and mentor!
Spotify: open.spotify.com/episode/0NBd...
Really nice to see #lobular #breastcancer get its own session at the recent Canadian Breast Cancer Symposium #CBCS25, with @lobularbca.bsky.social board members in attendance!
15% of all breast cancers are Lobular, 2000 per day. It's hard to detect, with little knowledge of its biology, so no specific treatments. The Lobular Moon Shot project is tirelessly pursuing support for ambitious, life changing research #LivedExperience #Lobular #BreastCancer #LobularMoonShot
I enjoyed reading this well-thought-out review on clinical challenges and proposed solutions for patients with invasive #lobular #breastcancer Oncologywww.annalsofoncology.org/article/S0923-7534%2825%...
New review from us on radiation in #lobular breast cancer!
www.nature.com/articles/s41...
Lots of anecdote that ILC is highly responsive to XRT (despite ~chemoresistance), but do we have the data?
led by Dr. Michael Boysen (now resident at Trinity Health Ann Arbor), w Dr. Corey Speers @ UAB. 🧵1/n
We did a thing w @jostrander.bsky.social!
Over the last few years, we took a new direction into #lobular breast cancer oncogenesis. We know loss of the gene CDH1 (E-cadherin) is central to ILC, and is among its earliest oncogenic events. But why? How does this push normal breast toward cancer? 1/n
Congrats to Dr. Maggie Musick on her 1st lead-author study in the lab! This #lobular project with @jostrander.bsky.social has been so much fun over the last few years.
Blue-torial soon, after a grant gets out the door this week 🫠
May the Fourth be with you.
Carved in my memory and on my chest, it's my seventh mastectoversary.
A tough old road, but still here.
#ThanksCancer #BreastCancer #LobMob #Lobular #ILC #CanSky
Histology DOES matter in breast cancer biology! Really excited for #lobular to be featured at #AACR25 and to share the stage with Drs. Steffi Oesterreich and Christina Curtis.
Matt in front of the cover slide reading 'Social determinants of health and cancer outcomes: from the sidewalk to the bench and back again".
Made it to AACR! This is my 20 year anniv of membership, w/ my first meeting in 2005 as an undergrad Bardos Scholar.
On Monday I'll be speaking in #lobular breast cancer session -
eppro02.ativ.me/appinfo.php?...
Kicking off #AACR25 on the cancer disparities track!
@theaacr.bsky.social
Uncovering synthetic lethal vulnerabilities across cancers. Upregulation of #TWIST1/2, #VIM, and integrin components ( #ITGB5, #ITGAV, #FERMT2 ) constitutes a synthetic lethal buffering mechanism that preserves tumor fitness despite #CDH1 #Ecadherin loss #lobular #DGC
www.nature.com/articles/s41...
The Sikora Lab & @cucancercenter.bsky.social rcvd a 2025 microgrant from the Breast Cancer Care & Research Fund to support our #lobular breast cancer outreach with @charlevo.bsky.social and Front Range ILC! BCCRF helped get FRILC off the ground in '22 and we're grateful for their ongoing support.
Enjoyed speaking on #lobular #breastcancer at the 2025 updates in #generalsurgery conference. @uoftsurgery.bsky.social
Looking forward to speaking about #TNBC at the lunchtime symposium .
Wonderful presentations from a truly inspiring #Lobular Breast Cancer Symposium 2024 in Leuven!
Happy viewing! #CDH1 #ILC #TME #ImmunoILC #LOXL1 @elbcc-2018.bsky.social
www.youtube.com/watch?v=g7IN...
www.youtube.com/watch?v=g7IN...
www.youtube.com/watch?v=P56x...
www.youtube.com/watch?v=rOLa...
A Comprehensive Overview of Lobular Breast Cancer from the leaders of the new Memorial Sloan Kettering lobular breast cancer program #lobular #breastcancer #lobularbreastcancer #ILC #BREASTCANCER #CDH1
www.youtube.com/watch?v=gtZt...
The latest newsletter from the Sikora Lab and Front Range ILC is up! Features in this 'issue':
- Quick info on 'indirect' costs for advocates
- Info and registration link for our Spring '25 outreach event (on 4/11 - come join us!)
- Tracy's story re: full body MRI for cancer screening
#lobular
